Cargando…

Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma

To determine the suitability of serum endocan (ESM-1) levels for diagnosing and monitoring renal cell carcinoma (RCC), we measure serum ESM-1 levels in 56 RCC patients who had undergone radical or partial nephrectomies and 56 age- and sex-matched healthy kidney donors. Measurements were made before...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwang Hyun, Lee, Hyung Ho, Yoon, Young Eun, Na, Joon Chae, Kim, Sook Young, Cho, Young In, Hong, Sung Joon, Han, Woong Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787497/ https://www.ncbi.nlm.nih.gov/pubmed/29416643 http://dx.doi.org/10.18632/oncotarget.23087

Ejemplares similares

Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker
por: Kim, Kwang Hyun, et al.
Publicado: (2019)

Exogenous pentraxin-3 inhibits the reactive oxygen species-mitochondrial and apoptosis pathway in acute kidney injury
por: Lee, Hyung Ho, et al.
Publicado: (2018)

Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma
por: Na, Joon Chae, et al.
Publicado: (2020)

Tubular organotypic culture model of human kidney
por: Jun, Dae-young, et al.
Publicado: (2018)

The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease
por: Yoon, Kyung Hee, et al.
Publicado: (2016)

Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma
por: Gu, Young-Ran, et al.
Publicado: (2022)

TNF-α-induced Inflammation Stimulates Apolipoprotein-A4 via Activation of TNFR2 and NF-κB Signaling in Kidney Tubular Cells
por: Lee, Hyung Ho, et al.
Publicado: (2017)

Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020)

Characteristics of Serum Endocan Levels in Infection
por: Seo, Kazunori, et al.
Publicado: (2015)

Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
por: Ozaki, Kazuaki, et al.
Publicado: (2014)

Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model
por: Yoon, Young Eun, et al.
Publicado: (2015)

Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019)

Retroperitoneal single-site robot-assisted partial nephrectomy using Lapsingle Vision advanced access platform: initial three case reports
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Robot-assisted laparoendoscopic single-site upper urinary tract surgery with da Vinci Xi surgical system: Initial experience
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Practical ESM analysis
por: Robertson, Sue
Publicado: (2019)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Serum endocan levels in patients with stable COPD
por: Pihtili, Aylin, et al.
Publicado: (2018)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
por: Lee, Yu Ho, et al.
Publicado: (2016)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Endocan as a marker of microvascular inflammation in kidney transplant recipients
por: Lee, Yu Ho, et al.
Publicado: (2019)

Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses
por: Han, Jang Hee, et al.
Publicado: (2017)

Serum endocan levels in women with restless legs syndrome
por: Celik, Kenan, et al.
Publicado: (2015)

Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022)

ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells
por: Jin, Hana, et al.
Publicado: (2020)

Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020)

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
por: El-Senosy, Fatma M., et al.
Publicado: (2022)

Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas
por: Choi, Jae Hyeok, et al.
Publicado: (2015)

Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019)

Serum endocan level and diastolic functions in the case of lead exposure
por: KARA, Halil, et al.
Publicado: (2019)

Investigation of Serum Endocan Levels and Age in Critical Inflammatory Conditions
por: Keskinidou, Chrysi, et al.
Publicado: (2023)

Impact of acute renal failure on plasmatic levels of cleaved endocan
por: Gaudet, Alexandre, et al.
Publicado: (2019)

Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance
por: Li, Yu-kun, et al.
Publicado: (2023)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia
por: Gunaydin, Senay, et al.
Publicado: (2019)

Is endocan a novel potential biomarker of liver steatosis and fibrosis?
por: Klisić, Aleksandra, et al.
Publicado: (2020)

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
por: Lee, Han Ah, et al.
Publicado: (2021)

Serum Endocan Levels Associated with Hypertension and Loss of Renal Function in Pediatric Patients after Two Years from Renal Transplant
por: de Souza, Livia Victorino, et al.
Publicado: (2016)

Serum endocan levels before and after surgery on low-grade gliomas
por: Tanriverdi, Taner, et al.
Publicado: (2017)

The Role of Endocan in Cardiometabolic Disorders
por: Klisic, Aleksandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_80ruo2lntd76hm35g8180jmv2o